Quarterly report pursuant to Section 13 or 15(d)

4. Notes Payable (Tables)

v3.5.0.2
4. Notes Payable (Tables)
6 Months Ended
Jun. 30, 2016
Debt Disclosure [Abstract]  
Schedule of notes payable
    June 30, 2016     December 31, 2015  
Loan payable under prepaid forward purchase contract   $ 5,000,000     $  
                 
Loan payable to TCA Global Master Fund, LP in the principal amount of $3,000,000 at 16% interest, with interest only payments through September 11, 2016 (the "TCA Debenture").  Principal and interest payments due monthly from October 11, 2016 through September 11, 2017.     3,000,000       3,000,000  
                 
Note payable to CommerceNet in the original principal amount of $250,000, bearing interest at 6% per annum. Principal and interest payments are made annually from July 12, 2015 through July 12, 2017     170,806       170,806  
                 
Note payable to Jay Tenenbaum in the original principal amount of $250,000, bearing interest at 6% per annum. Principal and interest payments are made annually from July 12, 2015 through July 12, 2017     170,806       170,806  
                 
Loan payable to former shareholder of Epinex Diagnostics Laboratories, Inc. in the original principal amount of $400,000, at 0% interest, with principal payments due in periodic installments of $100,000 from November 26, 2014 through February 26, 2016 (the "Epinex Note")           100,000  
                 
Unamortized discount on TCA Note     (305,188 )     (453,025 )
Unamortized discount on Epinex Note           (1,775 )
Derivative liability associated with the TCA Note, at fair value     420,333       186,117  
      8,456,757       3,172,929  
Less current portion     (7,546,335 )     (269,031 )
Note payable - third parties, net of current portion     910,422       2,903,898  
Schedule of notes payable - related parties
    June 30, 2016     December 31, 2015  
Convertible debenture dated December 31, 2014 which bears interest at 10% per annum and is due December 31, 2016 (the "D&D Debenture"). The note provides the lender, D&D Funding II, LLC, the option to convert the note into the Company's common stock at a 25% discount to the average trading price (as defined in the note agreement) for ten consecutive trading days prior to the conversion date   $ 750,000     $ 3,000,000  
                 
Loan payable to Alcimede, LLC, bearing interest at 6% per annum, with all principal and interest due on February 2, 2017     500,000       500,000  
                 
Loan payable to Christopher Diamantis     2,700,000       1,600,000  
                 
Loan payable to Thomas Mendolia     400,000        
                 
Unamortized discount on D&D Debenture     (297,843 )     (2,236,112 )
Derivative liabilities associated with the D&D Debenture, at fair value     1,060,833       2,270,000  
Current portion of notes payable, related parties     5,112,990       5,133,888